REFERENCES

  • Ahearn, E., Chen, P., Hertzberg, M., Cornette, M., Suvalsky, L., Cooley-Olson, D., … Krahn, D. (2013). Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. Journal of Affective Disorders, 145(1), 77–82. doi:10.1016/j.jad.2012.07.015
  • Akaike, H. (1987). Factor analysis and AIC. Psychometrika, 52(3), 317–332. doi:10.1007/BF02294359
  • Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006). Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disorders, 8(5p2), 625–639. doi:10.1111/j.1399-5618.2006.00344.x
  • Beasley, C. M., Ball, S. G., Nilsson, M. E., Polzer, J., Tauscher-Wisniewski, S., Plewes, J., & Acharya, N. (2007). Fluoxetine and adult suicidality revisited: An updated meta-analysis using expanded data sources from placebo-controlled trials. Journal of Clinical Psychopharmacology, 27(6), 682–686. doi:10.1097/jcp.0b013e31815abf21
  • Benson, T., O’Neill, S., Murphy, S., Ferry, F., & Bunting, B. (2014). Prevalence and predictors of psychotropic medication use: Results from the Northern Ireland study of health and stress. Epidemiology and Psychiatric Sciences, 24(6), 542–552. doi:10.1017/S2045796014000547
  • Bulloch, A. G. M., & Patten, S. B. (2010). Non-adherence with psychotropic medications in the general population. Social Psychiatry and Psychiatric Epidemiology, 45(1), 47–56. doi:10.1007/s00127-009-0041-5
  • Cavanagh, J. T. O., Carson, A. J., Sharpe, M., & Lawrie, S. M. (2003). Psychological autopsy studies of suicide: A systematic review. Psychological Medicine, 33(3), 395–405. doi:10.1017/S0033291702006943
  • Chaplin, R. (2007). How can clinicians help patients to take their psychotropic medication? Invited commentary on... Why don’t patients take their medicine? Advances in Psychiatric Treatment, 13(5), 347–349. doi:10.1192/apt.bp.107.003707
  • Chapman, S. C. E., & Horne, R. (2013). Medication nonadherence and psychiatry. Current Opinion in Psychiatry, 26(5), 446–452. doi:10.1097/YCO.0b013e3283642da4
  • Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013). Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ, 346, f3646. doi:10.1136/bmj.f3646
  • Collins, J. C., & McFarland, B. H. (2008). Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. Journal of Affective Disorders, 107(1–3), 23–28. doi:10.1016/j.jad.2007.07.014
  • Departments of Public Health. (2001). Suicide in Ireland: A national study. Retrieved from http://www.drugsandalcohol.ie/5723/1/Suicide_in_Ireland.pdf
  • Food and Drug Administration. (2002). Clozaril (clozapine) Tablets: Prescribing information. Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19758se1-047_Clozaril_lbl.pdf
  • Food and Drug Administration. (2005). Public health advisories (drugs) - Public health advisory: Suicidal thinking in children and adolescents being treated with Strattera (Atomoxetine). Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051733.htm
  • Food and Drug Administration. (2008). Postmarket drug safety information for patients and providers - Suicidal behavior and ideation and antiepileptic drugs. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.htm
  • Food and Drug Administration. (2009). Public health advisories (drugs) - Public health advisory: FDA requires new boxed warnings for the smoking cessation drugs Chantix and Zyban. Retrieved from http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm170906.htm
  • Gazalle, F. K., Hallal, P. C., Tramontina, J., Rosa, A. R., Andreazza, A. C., Zanatto, V., … Ceresér, K. M. (2007). Polypharmacy and suicide attempts in bipolar disorder. Revista Brasileira de Psiquiatria, 29(1), 35–38. doi:10.1590/S1516-44462006005000021
  • Gibbons, R. D., Brown, C. H., Hur, K., Davis, J., & Mann, J. J. (2012). Suicidal thoughts and behavior with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry, 69(6), 580–587. doi:10.1001/archgenpsychiatry.2011.2048
  • Goodwin, F. K., Fireman, B., Simon, G. E., Hunkeler, E. M., Lee, J., & Revicki, D. (2003). Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of the American Medical Association, 290(11), 1467–1473. doi:10.1001/jama.290.11.1467
  • Gu, Q., Dillon, C. F., & Burt, V. L. (2010). Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. Hyattsville, MD. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db42.pdf
  • Henriksson, S., Boëthius, G., & Isacsson, G. (2001). Suicides are seldom prescribed antidepressants: Findings from a prospective prescription database in Jämtland county, Sweden, 1985–95. Acta Psychiatrica Scandinavica, 103(4), 301–306. doi:0.1034/j.1600-0447.2001.00276.x
  • Ilgen, M. A., Kleinberg, F., Ignacio, R. V, Bohnert, A. S. B., Valenstein, M., McCarthy, J. F., … Katz, I. R. (2013). Noncancer pain conditions and risk of suicide. JAMA Psychiatry, 70(7), 692–697. doi:10.1001/jamapsychiatry.2013.908
  • Isacsson, G., Bergman, U., & Rich, C. L. (1994). Antidepressants, depression and suicide: An analysis of the San Diego study. Journal of Affective Disorders, 32(4), 277–286. doi:10.1016/0165-0327(94)90092-2
  • Isacsson, G., Boëthius, G., & Bergman, U. (1992). Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatrica Scandinavica, 85(6), 444–448. doi:10.1111/j.1600-0447.1992.tb03209.x
  • Joint Formulary Committee. (2013). British national formulary (66th ed.). London, UK: BMJ Group and Pharmaceutical Press.
  • Jones, C., Mack, K., & Paulozzi, L. (2013). Pharmaceutical overdose deaths, United States, 2010. JAMA, 309(7), 657–659. doi:10.1001/jama.2013.272
  • Lavigne, J. E., McCarthy, M., Chapman, R., Petrilla, A., & Knox, K. L. (2012). Exposure to prescription drugs labeled for risk of adverse effects of suicidal behavior or ideation among 100 air force personnel who died by suicide, 2006–2009. Suicide and Life-Threatening Behavior, 42(5), 561–566. doi:10.1111/j.1943-278X.2012.00112.x
  • Lo, Y., Mendell, N. R., & Rubin, D. B. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778. doi:10.1093/biomet/88.3.767
  • Manteuffel, M., Williams, S., Chen, W., Verbrugge, R. R., Pittman, D. G., & Steinkellner, A. (2014). Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. Journal of Women’s Health, 23(2), 112–119. doi:10.1089/jwh.2012.3972
  • Montgomery, S. A., Dunner, D. L., & Dunbar, G. C. (1995). Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. European Neuropsychopharmacology, 5(1), 5–13. doi:10.1016/0924-977X(94)00131-T
  • National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. (2014). Suicide in primary care in England: 2002—2011. Manchester, UK. Retrieved from http://www.bbmh.manchester.ac.uk/cmhr/research/centreforsuicideprevention/nci/reports/SuicideinPrimaryCare2014.pdf
  • Nylund, K. L., Asparouhov, T., & Muthén, B. O. (2007). Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling: A Multidisciplinary Journal, 14(4), 535–569. doi:10.1080/10705510701575396
  • Obermeyer, C. M., Schulein, M., Hardon, A., Sievert, L. L., Price, K., Santiago, A. C., … Neuman, M. (2004). Gender and medication use: An exploratory, multi-site study. Women & Health, 39(4), 57–73. doi:10.1300/J013v39n04_04
  • O’Neill, S., Corry, C. V, Murphy, S., Brady, S., & Bunting, B. P. (2014). Characteristics of deaths by suicide in Northern Ireland from 2005 to 2011 and use of health services prior to death. Journal of Affective Disorders, 168, 466–471. doi:10.1016/j.jad.2014.07.028
  • Paulose-Ram, R., Safran, M. A., Jonas, B. S., Gu, Q., & Orwig, D. (2007). Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology & Drug Safety, 16(5), 560–570. doi:10.1002/pds.1367
  • Quan, H., Arboleda-Flórez, J., Fick, G. H., Stuart, H. L., & Love, E. J. (2002). Association between physical illness and suicide among the elderly. Social Psychiatry and Psychiatric Epidemiology, 37(4), 190–7. doi:10.1007/s001270200014
  • Ram, N., & Grimm, K. J. (2009). Methods and measures: Growth mixture modeling: A method for identifying differences in longitudinal change among unobserved groups. International Journal of Behavioral Development, 33(6), 565–576. doi:10.1177/0165025409343765
  • Ramaswamy, V., Desarbo, W. S., Reibstein, D. J., & Robinson, W. T. (1993). An empirical pooling approach for estimating marketing mix elasticities with PIMS data. Marketing Science, 12(1), 103–124. doi:10.1287/mksc.12.1.103
  • Ruengorn, C., Sanichwankul, K., Niwatananun, W., Mahatnirunkul, S., Pumpaisalchai, W., & Patumanond, J. (2012). A risk-scoring scheme for suicide attempts among patients with bipolar disorder in a Thai patient cohort. Psychology Research and Behavior Management, 5, 37–45. doi:10.2147/PRBM.S30878
  • Schwarz, G. (1978). Estimating the dimension of a model. The Annals of Statistics, 6(2), 461–464. doi:10.1214/aos/1176344136
  • Sclove, S. L. (1987). Application of model-selection criteria to some problems in multivariate analysis. Psychometrika, 52(3), 333–343. doi:10.1007/BF02294360
  • Sendt, K.-V., Tracy, D. K., & Bhattacharyya, S. (2015). A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Research, 225(1–2), 14–30. Retrieved from http://www.scopus.com/inward/record.url?eid=2-s2.0-84916613158&partnerID=40&md5=0c353df8db8a7771419b4a43139daf12
  • Sharma, T., Guski, L. S., Freund, N., & Gøtzsche, P. C. (2016). Suicidality and aggression during antidepressant treatment: Systematic review and meta-analyses based on clinical study reports. BMJ, 352, i65. Retrieved from http://www.bmj.com/content/352/bmj.i65.abstract
  • Sun, Y., Lin, C.-C., Lu, C.-J., Hsu, C.-Y., & Kao, C.-H. (2016). Association between zolpidem and suicide: A nationwide population-based case-control study. In Mayo Clinic Proceedings. CONF, Elsevier.
  • Verkes, R. J., van der Mast, R. C., Hengeveld, M. W., Tuyl, J. P., Zwinderman, A. H., & van Kempen, G. M. (1998). Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. The American Journal of Psychiatry, 155(4), 543–547. doi:10.1176/ajp.155.4.543
  • Waern, M., Runeson, B. S., Allebeck, P., Beskow, J., Rubenowitz, E., Skoog, I., & Wilhelmsson, K. (2002). Mental disorder in elderly suicides: A case-control study. The American Journal of Psychiatry, 159(3), 450–455. doi:10.1176/appi.ajp.159.3.450
  • Wohlfarth, T. D., van Zwieten, B. J., Lekkerkerker, F. J., Gispen-de Wied, C. C., Ruis, J. R., Elferink, A. J. A., & Storosum, J. G. (2006). Antidepressants use in children and adolescents and the risk of suicide. European Neuropsychopharmacology, 16(2), 79–83. doi:10.1016/j.euroneuro.2005.10.004
  • World Health Organization. (2014). Preventing suicide: A global imperative. Geneva, Switzerland. Retrieved from http://apps.who.int/iris/bitstream/10665/131056/1/9789241564779_eng.pdf?ua=1&ua=1
  • Youssef, H. A. (1990). Psychotropic drugs in suicidal patients: A comparison of psychotropic medications in attempters and completed suicides. International Clinical Psychopharmacology, 5(4), 291–294. doi:10.1097/00004850-199010000-00007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.